Zdrowie i gospodarka · 30/12/1994

Barr Laboratories Withdraws FDA Proposal to Refuse Approval of Certain Drug Applications

The FDA is withdrawing a proposal to refuse approval of certain abbreviated drug applications submitted by Barr Laboratories, following the company's compliance with current good manufacturing practice regulations, ensuring the quality and purity of its products.